{"entity":{"type":"insider","cik":"0001982638","url":"/insider/0001982638","json_url":"/insider/0001982638.json","name":"Marshak Richard","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2025-05-21","last":"2026-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Marshak Richard","source":"filing","n_filings":3,"first_seen":"2025-05-21","last_seen":"2026-05-19"}],"transactions":[{"id":5884903,"accession":"0001628280-26-036427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-036427","line_url":"/filing/0001628280-26-036427#line-1","is_derivative":false,"issuer_cik":"0001826667","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001826667","owner_cik":"0001982638","owner_name":"Marshak Richard","owner_display_name":"Marshak Richard","owner_url":"/insider/0001982638","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":543.0,"shares_display":"543","price_per_share":2.67,"price_display":"2.67","price_state":"stated","total_value":1449.81,"total_display":"1,449.81","total_whole":"1,450","shares_owned_after":125101.0,"shares_owned_after_display":"125,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":5814431,"accession":"0001628280-26-020188","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-020188","line_url":"/filing/0001628280-26-020188#line-3","is_derivative":false,"issuer_cik":"0001826667","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001826667","owner_cik":"0001982638","owner_name":"Marshak Richard","owner_display_name":"Marshak Richard","owner_url":"/insider/0001982638","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":419.0,"shares_display":"419","price_per_share":4.12,"price_display":"4.12","price_state":"stated","total_value":1726.28,"total_display":"1,726.28","total_whole":"1,726","shares_owned_after":110397.0,"shares_owned_after_display":"110,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-20","scope":"insider"},{"id":5814429,"accession":"0001628280-26-020188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-020188","line_url":"/filing/0001628280-26-020188#line-2","is_derivative":false,"issuer_cik":"0001826667","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001826667","owner_cik":"0001982638","owner_name":"Marshak Richard","owner_display_name":"Marshak Richard","owner_url":"/insider/0001982638","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1589.0,"shares_display":"1,589","price_per_share":4.09,"price_display":"4.09","price_state":"stated","total_value":6499.01,"total_display":"6,499.01","total_whole":"6,499","shares_owned_after":110816.0,"shares_owned_after_display":"110,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-12","filed_date":"2026-03-20","scope":"insider"},{"id":5814427,"accession":"0001628280-26-020188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-020188","line_url":"/filing/0001628280-26-020188#line-1","is_derivative":false,"issuer_cik":"0001826667","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001826667","owner_cik":"0001982638","owner_name":"Marshak Richard","owner_display_name":"Marshak Richard","owner_url":"/insider/0001982638","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1449.0,"shares_display":"1,449","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":5984.37,"total_display":"5,984.37","total_whole":"5,984","shares_owned_after":112405.0,"shares_owned_after_display":"112,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-20","scope":"insider"},{"id":4744361,"accession":"0001826667-25-000057","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001826667-25-000057","line_url":"/filing/0001826667-25-000057#line-2","is_derivative":false,"issuer_cik":"0001826667","issuer_name":"TriSalus Life Sciences, Inc.","issuer_ticker":"TLSI","issuer_name_source":null,"issuer_url":"/issuer/0001826667","owner_cik":"0001982638","owner_name":"Marshak Richard","owner_display_name":"Marshak Richard","owner_url":"/insider/0001982638","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6597.0,"shares_display":"6,597","price_per_share":5.18,"price_display":"5.18","price_state":"stated","total_value":34172.46,"total_display":"34,172.46","total_whole":"34,172","shares_owned_after":69101.0,"shares_owned_after_display":"69,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-19","filed_date":"2025-05-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001826667","name":"TriSalus Life Sciences, Inc.","url":"/issuer/0001826667","role":"Officer (Chief Commercial Officer)","n_filings":3,"first_seen":"2025-05-21","last_seen":"2026-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001982638","retrieved_at":"2026-08-27T11:03:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}